Business Wire

Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection

BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug ...
Business Wire

Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim)

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that an inspection of the ...
Morningstar

SPECTRUM PHARMACEUTICALS (NASDAQ: SPPI) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Class Action by September 24, 2025

PHILADELPHIA, Sept. 8, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" ...
Seeking Alpha

Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction

LAKE FOREST, Ill., July 31, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, today announced that it has closed the ...
Morningstar

Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: 4-DAY DEADLINE in Securities Lawsuit- Hagens Berman

Spectrum Pharmaceuticals, Inc., et al., has been ongoing in the Southern District of New York since late 2022. It alleges that Spectrum repeatedly assured investors that its cancer treatment drug, ...
The Times of Northwest Indiana

Here's Why Spectrum Pharmaceuticals, Inc. Is Slipping Today

Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) are losing ground after the oncology-focused biotech's fourth-quarter earnings failed to impress on two fronts. The company's commercial-stage ...
MarketWatch

Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) Investor Alert: Today is the Lead Plaintiff Deadline in Securities Class Action - Hagens Berman

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals (SPPI) securities class action. This ...
ksn.com

Class Action Involving Spectrum Pharmaceuticals, Inc. (SPPI): Contact Robbins LLP if You Incurred Significant Financial Harm from Your Investment in Spectrum Pharmaceuticals, Inc.

The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all purchasers of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) common stock between December 6, 2021 and ...
KTLA

NASDAQ: SPPI CLASS ACTION NOTICE: Berger Montague Encourages Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action

PHILADELPHIA, Aug. 19, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" ...